⚕️

Medical Disclaimer

The information on this page is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always seek the advice of your doctor or other qualified health professional with any questions you may have regarding a medical condition.

🚨Emergency? If you have severe symptoms, difficulty breathing, or think it's an emergency, call 000 immediately.

Bone Cancer in Children and Young Adults (Osteosarcoma)

Osteosarcoma is the most common primary bone cancer in children, adolescents, and young adults (peak age 10-20 years), typically developing in the metaphysis (growing end) of long bones—most commonly around the knee (60-70% of cases: distal femur, proximal tibia) or proximal humerus (upper arm). It presents as progressively worsening bone pain (initially mistaken for growing pains), swelling, and occasionally a palpable mass, often following minor trauma that brings attention to the area. Osteosarcoma is an aggressive malignancy that produces abnormal bone (osteoid) and requires intensive multimodality treatment: neoadjuvant chemotherapy (pre-operative chemotherapy to shrink tumor, 8-12 weeks), limb salvage surgery (removing tumor while preserving limb function with endoprosthesis or allograft reconstruction, 90-95% of cases), and adjuvant chemotherapy (post-operative chemotherapy to kill micrometastases, 6-8 months total). With modern treatment protocols, 5-year survival is 65-70% for localized disease, though metastatic disease at presentation (20% of cases, usually lung) has poorer prognosis (30-40% survival).

📅Last reviewed: January 2025🏥Bones & Joints

📖What is Bone Cancer in Children and Young Adults (Osteosarcoma)?

Osteosarcoma is the most common primary bone cancer in children, adolescents, and young adults (peak age 10-20 years), typically developing in the metaphysis (growing end) of long bones—most commonly around the knee (60-70% of cases: distal femur, proximal tibia) or proximal humerus (upper arm). It presents as progressively worsening bone pain (initially mistaken for growing pains), swelling, and occasionally a palpable mass, often following minor trauma that brings attention to the area. Osteosarcoma is an aggressive malignancy that produces abnormal bone (osteoid) and requires intensive multimodality treatment: neoadjuvant chemotherapy (pre-operative chemotherapy to shrink tumor, 8-12 weeks), limb salvage surgery (removing tumor while preserving limb function with endoprosthesis or allograft reconstruction, 90-95% of cases), and adjuvant chemotherapy (post-operative chemotherapy to kill micrometastases, 6-8 months total). With modern treatment protocols, 5-year survival is 65-70% for localized disease, though metastatic disease at presentation (20% of cases, usually lung) has poorer prognosis (30-40% survival).

🔬What Causes It?

  • Unknown cause in most cases (sporadic—no identifiable trigger)
  • Rapid bone growth during adolescent growth spurt (tumors occur in fastest-growing bones)
  • Genetic mutations in tumor suppressor genes (RB, p53) in sporadic cases
  • Hereditary cancer syndromes (Li-Fraumeni syndrome, hereditary retinoblastoma) in 5-10% of cases
  • Previous radiation exposure (secondary osteosarcoma developing 10-20 years after radiation for other cancer)
  • Paget's disease of bone (rare cause in elderly patients)

⚠️Risk Factors

ℹ️

You may be at higher risk if:

  • Age 10-20 years (peak incidence during adolescent growth spurt)
  • Male gender (1.5 times more common than females)
  • Height (taller adolescents at slightly higher risk)
  • Family history of hereditary cancer syndromes (Li-Fraumeni, retinoblastoma)
  • Previous radiation therapy for other cancers
  • Paget's disease (in older adults)

🛡️Prevention

  • No known prevention for sporadic osteosarcoma (most common type)
  • Genetic counseling for families with hereditary cancer syndromes
  • Early evaluation of persistent bone pain in children/adolescents
  • Avoid unnecessary radiation exposure when possible